Press Enter to Main Content
您的瀏覽器似乎不支援JavaScript語法,但沒關係,這裡的JavaScript語法並不會影響到內容的陳述, 如需要選擇字級大小,IE6請利用鍵盤按住ALT鍵+ V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小, 而IE7或Firefox瀏覽器則可利用鍵盤 Ctrl + (+)放大(-)縮小來改變字型大小,如需要回到上一頁可使用瀏覽器提供的 Alt+左方向鍵(←) 快速鍵功能,列印可使用瀏覽器提供的(Ctrl+P)功能。
  • facebook
  • line
  • twitter
  • Print
  • Back

Continuing to deepen the partnership with new southbound countries, promoting bilateral cooperation comprehensively

  • Data Source:Food and Drug Administration, Ministry of Health and Welfare
  • Created:2019-10-03
  • Last Updated:2019-10-03

Taiwan Food and Drug Administration (TFDA) has actively promoted the New Southbound Policy for three years. TFDA had invited the officers and experts, such as Malaysia, Vietnam, Thailand, Singapore, India, Philippines, Australia and New Zealand, and hosted seven international conferences, five government meetings and one working group meeting of international organization in 2019. In the second half of 2019, TFDA has been supported by Asia-Pacific Economic Cooperation (APEC) to host the seminar on the Medical Device Regulation Center of Excellence pilot workshop. TFDA plan to invite new southbound partners to participate in the seminar, and hope to enhance the partnership and expand influence in the region.


The New Southbound Policy plays an important role in Taiwan's economic and trade strategies, and the implementation outcome has received high social attention. TFDA promotes mainly through "training the professionals from new southbound countries", "regulatory harmonization" and "regional industrial chain collaboration". TFDA also devotes itself to domestic pharmaceutical and food industry development for entering new southbound markets. TFDA hopes to build mutual trust and benefit by strengthening bilateral relations with new southbound partner countries and creating a win-win, which aims to redefine Taiwan's position in Asia and even in the global community.